Leading drugmakers rushing to increase subsidiaries

Published: 2011-09-05 07:00:00

Updated: 2011-09-05 07:00:00

Korea’s major drug firms have increased their number of affiliates, an expansion that is feared will divert them from their core businesses and weaken their competitiveness.

According to the Ministry of Health and Welfare and the Financial Supervisory Service, the top 10 pharmaceutical compani...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK